Skip to content

Effect of Transversus Thoracic Muscle Plane Block (TTMP) on Analgesia

Investigation of the Efficacy of Transversus Thoracic Muscle Plane Block in Patients Undergoing Coronary Artery Bypass Graft Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06601530
Enrollment
46
Registered
2024-09-19
Start date
2022-08-01
Completion date
2022-10-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass, Anesthesia, Conduction, Nerve Block, Pain, Postoperative

Keywords

Transversus thoracic muscle plane block, postopertive pain, sternotomy

Brief summary

In this prospective and controlled study, the investigators investigated the effect of transversus thoracic muscle plane block (TTMP) on analgesia in patients who undergo coronary artery bypass graft (CABG) surgery with median sternotomy. For this purpose, the investigators aimed to compare the hemodynamic responses to surgical incision and sternotomy and, pain intensity, total analgesic consumption, additional analgesic requirements of the patients in the first 24 hours after extubation under postoperative patient-controlled analgesia (PCA) adminisration.

Detailed description

Forty-six patients aged 18-70 years, ASA class I-III, who undergo CABG surgery were included in our study. The patients were randomized into the TTKPB group and the control group. Heart rate (HR) and mean arterial pressure (MAP) were recorded before peroperative induction, before skin incision, after skin incision, before sternotomy and after sternotomy. PCA with tramadol was applied after extubation and Numeric rating scale NRS scores, total tramadol consumption, number of requests and additional analgesic requirements were recorded at 0, 1, 2, 4, 8, 12 and 24 hours.

Interventions

Transversus thoracic muscle plane block is a single-shot nerve block technique that provides analgesia for the anterior chest wall Tramadol IV PCA (Patient Controlled Analgesia): Basal infusion 0.2 mg/kg/h, bolus 20 mg, lock time 20 minutes

DRUGTramadol

Tramadol IV PCA (Patient Controlled Analgesia): Basal infusion 0.2 mg/kg/h, bolus 20 mg, lock time 20 minutes

Sponsors

Istanbul University - Cerrahpasa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ASA (American Society of Anesthesiologists) classification I-III * Coronary artery bypass graft operation with median sternotomy under elective conditions

Exclusion criteria

* Refusing to participate in the study * Under 18 and over 70 * ASA class IV and above * EF (Ejection Fraction) \< 40% * Emergency surgery or reoperation * Intraaortic balloon pump placement * Known allergy to local anesthetics * Coagulation disorder * Infection at the block site * History of sternotomy * Those with chronic pain complaints and long-term use of analgesics * Patients who could not be extubated within 12 hours after the operation

Design outcomes

Primary

MeasureTime frameDescription
Mean arterial pressurePostoperative 24 hoursPostoperative 0, 1, 2, 4, 8, 12 and 24 hours
Heart ratePostoperative 24 hoursPostoperative 0, 1, 2, 4, 8, 12 and 24 hours
Numeric Rating Scale (NRS) at restPostoperative 24 hoursNumeric Rating Scale (NRS) for postoperative pain
Numeric Rating Scale (NRS) during coughingPostoperative 24 hoursNumeric Rating Scale (NRS) for postoperative pain
Bispectral Index (BIS)PeroperativePeroperative induction, before skin incision, after skin incision, before sternotomy and after sternotomy.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026